Also trades as: 0JDK.L (LSE) · $vol 0M
IOVA NASDAQ
Iovance Biotherapeutics, Inc.
1W: +5.1%
1M: +4.8%
3M: +28.9%
YTD: +46.8%
1Y: +93.7%
3Y: -50.6%
5Y: -85.7%
$4.11
+0.41 (+11.08%)
Weekly Expected Move ±11.0%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$286M
Revenue
+34.3% YoY
$-354M
Net Income
+5.7% YoY
$-305M
Free Cash Flow
+12.2% YoY
98.6%
Gross Margin
-113.5%
Op. Margin
-110.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-50.2%
ROA-38.8%
ROIC-63.8%
Valuation
P/E-4.9
P/B2.4
EV/EBITDA-3.7
Leverage
Debt/Equity0.07
Current Ratio3.20
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z-0.74
Beneish M-3.13